As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...

NEW YORK — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal government to haggle directly ...

The One Big Beautiful Bill Act removed a number of orphan drugs from being subject to price negotiations, and this could cost the Medicare program $8.8 billion over the course of about 10 years. That ...

The proposed changes are relatively modest, yet they represent an important procedural step forward in the implementation of the Medicare Drug Price Negotiation Program. In this article, we describe ...

On Monday, the Supreme Court declined to hear appeals from pharmaceutical companies opposing the federal government's ability to negotiate drug prices under Medicare. This decision maintains the lower ...

“While we support affordable health care, the price controls that we are challenging would reduce access to new medicines that Americans are counting on, and would set a devastating precedent for all ...

On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...

The Centers for Medicare and Medicaid Services recently announced negotiated prices for 15 drugs, finalizing the second iteration of the Medicare Drug Price Negotiation Program. The first set of ...

“The Program cannot qualify as a physical taking under the Takings Clause because it does not ‘compel the surrender’ of property, or impose any ‘physical invasion or restraint upon’ it, and the owner ...